Search PubMed⌕ Search

Biomedical subjects

M Adinolfi

Publications and source records attributed to M Adinolfi.

At least 127 records · Page 7Linked to original sources
PubMed1977

Ontogeny of human lysozyme. Distribution in fetal tissues.

Using the immunoperoxidase method, major changes in the distribution of lysozyme (LZM) were found to occur during fetal development. At 10 weeks of gestation LZM was detected for the first time in the proximal tubules of the kidney. This generally coincides with the reported appearance of LZM in fetal blood and amniotic fluid. The enzyme was observed in lung macrophages and in mononuclear cells of the lamina propria of the small intestine in fetuses 12 and 16 weeks old, respectively. At about 18--20 weeks, LZM-positive mononuclear cells were detected in other tissues tested, such as liver, spleen and thymus. Paneth cells were found to be specifically stained at about 20 weeks of gestation. The timing of the appearance of LZM in the various tissues is discussed in relation to the functional maturation of each organ and the ontogeny of this enzyme in other species.

Amniotic Fluid↗
PubMed1976

Levels of beta-trace protein and lysozyme in human amniotic fluids.

The levels of beta-trace protein and lysozyme were estimated in amniotic fluids from normal fetuses and from fetuses with neuraltube defects. The values of these proteins in normal amniotic fluids were found to be similar to those detected in fetuses with anencephaly and spina bifida. The levels of lysozyme were shown to be correlated with gestational age.

Albumins↗
PubMed1976

Levels of alpha-fetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects.

Mutant curly-tail mice are genetically predisposed to produce offspring with neural tube defects. Estimation of alpha-fetoprotein in the amniotic fluid of fetuses of these mutants has shown that the levels are raised in fetuses with exencephaly and open spina bifida. This suggests that these mice are a valid model for studies of the aetiology and genesis of neural tube defects in man.

Amniotic Fluid↗
PubMed1976

Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.

Estimation of the concentration of C9, C-reactive protein (CRP) and alpha1-antitrypsin in forty sera from patients with Behcet's syndrome and recurrent oral ulcers showed significantly increased amounts of C9 and CRP in Behcet's syndrome. The concentration of C9 was also significantly raised in recurrent oral ulceration, though to a lesser extent than in Behcet's syndrome. The assay C9 and CRP might be useful in the differential diagnosis of Behcet's syndrome, especially from recurrent oral ulcers. It is suggested that during epithelial inflammation in recurrent oral ulcers some of the acute phase proteins are increased and in some patients these may modulate the immunological mechanism in such a way as to induce a transition from focal oral ulceration to the multifocal Behcet's syndrome.

Behcet Syndrome↗
PubMed1975

Human complement C7 and C9 in fetal and newborn sera.

Using specific immune sera, C7, C9, and C3 activator were detected in sera from human fetuses more than 16 weeks old and in newborn samples. Levels of C9 in cord sera ranged between 10 and 30% of those present in sera from adult subjects. The mean value of Ce activator was about half that in maternal blood. The mean level of C7 in newborns was nearly 70% of the amount in normal adults.

Animals↗
PubMed1975

Alpha-feto-protein during development and in disease.

An alpha-feto-protein (AFP) is present in many mammals, in birds, and in sharks during development. The AFP present in different species have similar physicochemical properties and often have common antigenic determinants. Their study, both in health and disease, has provided a useful model for the understanding of other phase-specific antigens and the activation of the genes which control their synthesis. In the human fetus, the level of AFP falls with increasing maturity. The more sensitive methods of detection have disclosed that this fetal protein persists in trace amounts throughout life and its level increases in maternal blood during pregnancy. The principal sites of synthesis are the fetal liver and in some mammals, the yolk sac splanchnopleur. In humans as well as in mice and cows, it is notable that the synthesis of AFP is increased in liver cancer cells and that high levels of this protein are present in serum. Elevated values of AFP have also been detected in human subjects with undifferentiated tumours of the testis and ovary. A fall to normal levels has been noted in cases of complete remission after surgery and a return to high levels in patients who develop metastases. In some patients with hepatitis a temporary rise in the level of AFP has also been observed. In recent years, the detection of high levels of AFP in amniotic fluid has proved to be of great value for the prenatal diagnosis of neural-tube defects. Abnormal levels have also been found in the amniotic fluid or in maternal serum in cases of spontaneous abortion. Such measurements are now being assessed as a methodof monitoring abnormal pregnancy.

Amniotic Fluid↗
PubMed1971

Isolation and characterization of human foetal alpha-globulin (alpha 1F) from foetal and hepatoma sera.

The alpha 1F present in human foetal sera and the serum from a patient with hepatocellular carcinoma was isolated by immune precipitation using rabbit anti-alpha 1F. After labelling with 125I, some physicochemical properties of alpha 1F were investigated. The molecular weights of 125I-labelled alpha 1F isolated from foetal and hepatoma sera were 61,000 and 63,000, respectively. The protein was not dissociated in 6 M guanidine after complete reduction, showing that it contains a single peptide chain.

Alpha-Globulins↗